RSANMDA: Resampling based subview attention network for miRNA-disease association prediction
Many studies have demonstrated the importance of accurately identifying miRNA-disease associations (MDAs) for understanding disease mechanisms. However, the number of known MDAs is significantly fewer than the unknown pairs. Here, we propose RSANMDA, a subview attention network for predicting MDAs....
Gespeichert in:
Veröffentlicht in: | Methods (San Diego, Calif.) Calif.), 2024-10, Vol.230, p.99-107 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Many studies have demonstrated the importance of accurately identifying miRNA-disease associations (MDAs) for understanding disease mechanisms. However, the number of known MDAs is significantly fewer than the unknown pairs. Here, we propose RSANMDA, a subview attention network for predicting MDAs. We first extract miRNA and disease features from multiple similarity matrices. Next, using resampling techniques, we generate different subviews from known MDAs. Each subview undergoes multi-head graph attention to capture its features, followed by semantic attention to integrate features across subviews. Finally, combining raw and training features, we use a multilayer scoring perceptron for prediction. In the experimental section, we conducted comparative experiments with other advanced models on both HMDD v2.0 and HMDD v3.2 datasets. We also performed a series of ablation studies and parameter tuning exercises. Comprehensive experiments conclusively demonstrate the superiority of our model. Case studies on lung, breast, and esophageal cancers further validate our method's predictive capability for identifying disease-related miRNAs.
•We propose to apply the resampling technique to the model, which improves the accuracy and stability of the prediction.•We propose the subview attention and the subview semantic attention to extract features of miRNAs and diseases.•Case studies on three categories of cancers indicate that RSANMDA is powerful for revealing disease related miRNAs. |
---|---|
ISSN: | 1046-2023 1095-9130 1095-9130 |
DOI: | 10.1016/j.ymeth.2024.07.007 |